Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Henlius Receives Positive CHMP Opinion for HANSIZHUANG as First-Line Treatment for Extensive-Stage Small Cell Lung Cancer 2024-09-21 13:42
European Wellness Unveils Premier Medical Wellness Center in Kota Kinabalu, Sabah: A Landmark in Global Healthcare 2024-09-21 09:00
Biosyngen Best-in-Class Next-Generation Tumor-Infiltrating Lymphocyte (TIL) Technology Debuts on ESMO 2024 Annual Meeting 2024-09-20 20:30
Kangpu Completed Bridging Clinical Study of KPG-818 in China 2024-09-20 20:00
CD (Suzhou) Biopharma Announces FDA Clearance for Phase I Clinical Trial of CD-001 2024-09-20 16:28
Frost & Sullivan grants the Global Cognitive Impairment Digital Therapy Innovation Award to BRAINAU 2024-09-19 21:48
Biosyngen Presents Pioneering"Conditional Activation + Armor Enhancement" SUPER-T technology at ESMO 2024 2024-09-19 20:30
Sirnaomics Announces Demonstration of a Novel Mechanism of Action of Its siRNA Therapeutics for Focal Fat Reduction in Journal of Cosmetic Dermatology 2024-09-19 17:28
Illumina and LGC Biosearch Technologies join forces to drive genomic innovation in agriculture 2024-09-19 14:00
MGI Tech partners with Dasa to enhance health diagnosis with genetic sequencing in Brazil 2024-09-19 11:05
Best Poster of ESMO 2024! Abbisko Announces Updated Clinical Data of Irpagratinib in HCC 2024-09-19 09:00
Watson-Marlow unveils Qdos™ H-FLO and WMArchitectTM :Innovating fluid solutions for the chemical and biopharmaceutical industries respectively 2024-09-19 08:00
Transcenta Updates Encouraging Efficacy Data from First-line Triple Combo Trial of Osemitamab (TST001) for G/GEJ Cancer at ESMO 2024 2024-09-19 08:00
Zymo Research Stands by Its Innovative cfDNA Technology in Response to Qiagen's Lawsuit 2024-09-18 22:00
Insilico Medicine Reports Positive Phase IIa Results for ISM001-055, a Novel First-in-Class Drug Treatment for Idiopathic Pulmonary Fibrosis (IPF) Designed Using Generative AI 2024-09-18 21:30
Biosyngen's first-in-class CAR-T asset targeting solid tumors has entered pivotal phase II trial, Phase I trial data debut at ESMO 2024 Annual Congress 2024-09-18 18:18
Frost & Sullivan grants the Global Medical Imaging Foundation Model Innovation Award to Hangzhou Diagens Biotechnology Co.,Ltd. 2024-09-18 16:16
Clarivate Announces 15th Annual Pharmavision India Conference Agenda 2024-09-18 15:00
Breakthrough in Long COVID: An investigator-initiated trial (IIT) with Hyundai Bioscience's Xafty by UCSD 2024-09-18 09:26
BioDuro-Sundia Appoints Dr. Armin Spura as New Chief Executive Officer 2024-09-18 08:30
1 18 19 20 21 22 458